Rights and permissions
About this article
Cite this article
Infliximab plus methotrexate cost effective in RA. Pharmacoecon. Outcomes News 388, 5 (2002). https://doi.org/10.1007/BF03279832
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279832